医学
镇静
四分位间距
麻醉
体外膜肺氧合
异丙酚
急性呼吸窘迫综合征
咪唑安定
芬太尼
回顾性队列研究
谵妄
中止
呼吸窘迫
镇静剂
外科
重症监护医学
肺
内科学
作者
Julian deBacker,Erik Tamberg,Laveena Munshi,Lisa D. Burry,Eddy Fan,Sangeeta Mehta
出处
期刊:Asaio Journal
[Lippincott Williams & Wilkins]
日期:2017-10-18
卷期号:64 (4): 544-551
被引量:61
标识
DOI:10.1097/mat.0000000000000658
摘要
Our objective was to characterize sedation management in adult patients with severe respiratory distress syndrome (ARDS) treated with venovenous extracorporeal membrane oxygenation (VV-ECMO). We conducted a retrospective chart review of these patients treated at Toronto General Hospital between January 2012 and October 2015. Medications administered (sedative, analgesic, paralytic, and antipsychotic), sedation depth (Sedation Agitation Scale [SAS] score) delirium assessments, and mobilization were recorded daily. Forty-five adults (33 males, median age 47 years; interquartile range [IQR], 35-56]) with ARDS (median PaO2/FiO2 71; IQR 59-83) because of respiratory infection (91%) were treated with VV-ECMO for a median of 11 days (IQR, 7-17). After ECMO initiation, 96% patients were deeply sedated (SAS score < 3) with continuous infusions of midazolam (49%), propofol (18%), or both (29%) and 98% were receiving opioid infusions (93% fentanyl). Patients were deeply sedated for a median of 6 days (IQR, 3-10) after cannulation before transitioning to intermediate or light sedation (SAS score ≥ 3). Before ECMO discontinuation, 77% of surviving patients were intermediately or lightly sedated, 20% were receiving no sedatives, and 9% were receiving no opioids. During ECMO, 58% had positive delirium assessment and 24% experienced agitation (SAS ≥ 6). During ECMO support, 71% received physical therapy that occurred after a median of 7 days (IQR, 4-12) after cannulation. In conclusion, we found that although patients were deeply sedated for a prolonged duration after VV-ECMO initiation, many were able to safely achieve light sedation and active mobilization.
科研通智能强力驱动
Strongly Powered by AbleSci AI